Aspects on Diagnosis and Treatment of the Foregut Carcinoid Syndrome

References

• Williams E D, Sandler M. The classification of carcinoid tumours. Lancet 1963; 1: 238
   PubMed Web of Science ®Google Scholar
• Grahame-Smith D G. The carcinoid syndrome. W. Heinemann Medical Books, Ltd, London 1972; 18–20
   Google Scholar
• Wängberg B, Ahlman H, Nilsson O, Haglid K, Denney R M, Dahlström A. Amine handling properties of human carcinoid tumour cells in tissue culture. Neurochem Int 1990; 17: 331
   PubMed Web of Science ®Google Scholar
• Masson P. Carcinoids (argentaffin cell tumours) and nerve hyperplasia of appendicular mucosa. Am J Pathol 1928; 4: 181
   PubMedGoogle Scholar
• Pentillä A. Histochemical reactions of the enterochromaffin cells and the 5-hydroxytryptamine content of the mammalian duodenum. Acta Physiol Scand 1966; 74, Suppl 281
   Google Scholar
• Norheim I, Theodorsson-Norheim E, Brodin E, Öberg K. Tachykinins in carcinoid tumours: the use as a tumour marker and possible role in the carcinoid flush. J Clin Endocrinol Metabol 1986; 53: 605
   Google Scholar
• Granérus G, Lindell S E, Waldenström J, Westling H, White T. Histamine metabolism in carcinoidosis. Lancet 1966; 1: 1267
   PubMed Web of Science ®Google Scholar
• Grahame-Smith D G. What is the cause of the carcinoid flush?. Gut 1987; 28: 1413
   PubMed Web of Science ®Google Scholar
• Frölich J C, Bloomgarten Z T, Oates J A, McGuigan J E, Rabinowitz D. The carcinoid flush. Provocation by pentagastrin and inhibition by somatostatin. N Engl J Med 1986; 299: 1055
   Google Scholar
• Sandler M, Snow P JD. An atypical carcinoid tumour secreting 5-hydroxytryptophan. Lancet 1958; 1: 137
   PubMed Web of Science ®Google Scholar
• Oates J A, Sjoerdsma A. A unique syndrome associated with secretion of 5-hydroxytryptophan by metastatic gastric carcinoids. Am J Med 1962; 32: 333
   PubMed Web of Science ®Google Scholar
• Berge T, Linell F. Carcinoid tumours. Acta Pathol Microbiol Scand 1976; 84A: 322
   Google Scholar
• Lönroth H, Håkanson R, Lundell L, Sundler F. Histamine containing cells in the human stomach. Gut 1990; 31: 383
   PubMed Web of Science ®Google Scholar
• Wilander E, El-Salhy M, Pitkanen P. Histopathology of gastric carcinoids; a survey of 42 cases. Histopathology 1984; 8: 183
   PubMed Web of Science ®Google Scholar
• Christodoulopoulos J B, Klotz A P. Carcinoid syndrome with primary tumour of the stomach. Gastroenterology 1961; 40: 429
   PubMed Web of Science ®Google Scholar
• Creutzfeldt W. The achlorhydria-carcinoid sequence: role of gastrin. Digestion 1988; 39: 61
   PubMed Web of Science ®Google Scholar
• Editorial. Bronchial adenomas. Br Med J 1987; 282: 252
   Google Scholar
• Mårtensson H, Böttcher G, Hambraeus G, Sundler F, Willén H, Nobin A. Bronchial carcinoids. An analysis of 91 cases. World J Surg 1987; 11: 356
   PubMed Web of Science ®Google Scholar
• Todd T R, Cooper J D, Weissberg D, Delaune N C, Pearson G. Bronchial carcinoid tumours. Twenty years' experience. J Thorac Cardiovasc Surg 1980; 79: 532
   PubMed Web of Science ®Google Scholar
• Blöndal T, Grimelius L, Nou E, Wilander E, Åberg T. Argyrophil carcinoid tumours of the lung. Incidence, clinical study and follow-up of 46 patients. Chest 1980; 78: 840
   PubMed Web of Science ®Google Scholar
• Goodner J T, Berg J W, Watson W L. The non-benign nature of bronchial carcinoids and cylindromas. Cancer 1961; 14: 539
   PubMed Web of Science ®Google Scholar
• Turnbull A D, Huvos A G, Goodner J T, Beattie E J. The malignant potential of bronchial adenoma. Ann Thorac Surg 1972; 14: 453
   PubMedGoogle Scholar
• Markel S F, Abell M R, Haight C, French A J. Neoplasms of bronchus commonly designated as adenomas. Cancer 1964; 17: 590
   PubMed Web of Science ®Google Scholar
• O'Grady W P, McDivitt R W, Holman C W, Moore S W. Bronchial adenomas. Arch Surg 1970; 101: 558
   PubMedGoogle Scholar
• Williams E D, Azzopardi J G. Tumours of the lung and the carcinoid syndrome. Thorax 1960; 15: 30
   PubMedGoogle Scholar
• Arrigoni M G, Wollner L B, Bernatz P E. Atypical carcinoid tumours of the lung. J Thorac Cardiovasc Surg 1972; 64: 413
   PubMed Web of Science ®Google Scholar
• Comi R J, Maton P N, Go V LW, Gorden P. Somatostatin and somatostatin analogue (SMS 201–995) in treatment of hormone-secreting tumors of the pituitary and gastrointestinal tract and non-neoplastic diseases of the gut. Ann Intern Med 1989; 110: 35
   PubMed Web of Science ®Google Scholar
• Schally A V. Oncological applications of somatostatin analogues. Cancer Res 1988; 48: 6977
   PubMed Web of Science ®Google Scholar
• Ahlman H, Wängberg B, Jansson S, et al. Management of disseminated midgut carcinoid tumours. Digestion 1991; 49: 78–96
   PubMed Web of Science ®Google Scholar
• Öberg K, Funa K, Alm G. Effects of leukocyte interferon on clinical symptoms and hormone levels in patients with midgut carcinoid tumours and the carcinoid syndrome. N Engl J Med 1983; 309: 129
   PubMed Web of Science ®Google Scholar
• Öberg K, Norheim I, Lind E, et al. Treatment of malignant carcinoid tumours with human leucocyte interferon. Cancer Treat Rep 1986; 70: 1297
   PubMedGoogle Scholar
• Moertel C G, Rubin J, Kvols L K. Therapy of metastatic carcinoid tumour and the malignant carcinoid syndrome with recombinant leucocyte A interferon. J Clin Oncol 1989; 7: 865
   PubMed Web of Science ®Google Scholar
• Välimäki E, Järvinen H, Salmela P, Sane T, Sjöblom S-M, Pelkonen R. Therapy of metastatic carcinoid tumor with interferon—not as successful as suggested?. Cancer 1991; 62: 547
   Google Scholar
• Grimelius L, Wilander E. Silver stains in the study of endocrine cells of the gut and pancreas. Invest Cell Pathol 1980; 3: 3
   PubMedGoogle Scholar
• Hsu S-M, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxide technique. A comparison between ABC and unlabelled antibody (PAP) procedures. J Histochem Cytochem 1981; 29: 577
   PubMed Web of Science ®Google Scholar
• Ahlman H, Åhlund L, Dahlström A, Martner J, Stenqvist O, Tylén U. SMS 201–995 and provocation tests in preparation of patients with carcinoids for surgery and hepatic arterial embolization. Anesth Analg (Cleve) 1988; 67: 1142
   PubMed Web of Science ®Google Scholar
• Salyer D C, Salyer W R, Eggleston J C. Bronchial carcinoid tumours. Cancer 1975; 36: 1522
   PubMed Web of Science ®Google Scholar
• Hasleton P S, Gomm S, Blair V, Thatcher N. Pulmonary carcinoid tumours: a clinico-pathological study of 35 cases. Br J Cancer 1986; 53: 963
   Google Scholar
• Mills S E, Walker A N, Cooper P H, Kron I L. Atypical carcinoid tumour of the lung: a clinicopathological study of 17 cases. Am J Surg Pathol 1982; 6: 643
   PubMed Web of Science ®Google Scholar
• Gould V E, Linnoila R I, Memoli V A, Warren W H. Neuroendocrine cells and neuroendocrine neoplasms of the lung. Pathol Ann 1983; 18: 287
   Google Scholar
• Gould V E, Linnoila R I, Memoli V A, Warren W H. Neuroendocrine components of the bronchopulmonary tract: hyperplasia, dysplasia, and neoplasms. Lab Invest 1983; 49: 519
   PubMed Web of Science ®Google Scholar
• Cuttitta F, Carney D N, Mulshine J L, et al. Bombesin-like peptides can function as autocrine growth factors in human small cell lung cancer. Nature 1985; 316: 823
   PubMed Web of Science ®Google Scholar
• McDowell E M, Wilson T S, Trump B F. Atypical endocrine tumours of the lung. Arch Pathol Lab Med 1988; 105: 973
   Google Scholar
• Neal M H, Kosinski R, Cohen P, Orenstein J M. Atypical endocrine tumours of the lung: a histological, ultrastructural, and clinical study of 19 cases. Hum Pathol 1986; 17: 1264
   PubMed Web of Science ®Google Scholar
• Erlandson R A. Carcinoid and atypical carcinoid (well-differentiated neuroendocrine carcinoma) of the lung. Ultrastruct Pathol 1989; 13: 373
   PubMed Web of Science ®Google Scholar
• Höög A, Gould V E, Grimelius L, Franke W W, Falkmer S, Shejfez G. Tissue fixation methods after the immunohisto-chemical demonstrability of synaptophysin. Ultrastruct Pathol 1988; 12: 673
   PubMed Web of Science ®Google Scholar
• Kaplan E L, Jaffe B M, Peskin G W. A new provocative test for the diagnosis of carcinoid syndrome. Am J Surg 1972; 123: 173
   PubMed Web of Science ®Google Scholar
• Ahlman H, Dahlström A, Grönstad K, et al. The pentagastrin test in the diagnosis of the carcinoid syndrome. Ann Surg 1985; 1: 81
   Google Scholar
• Öberg K, Norheim I, Theodorsson E, Ahlman H, Lundqvist G, Wide L. The effects of octreotide on basal and stimulated hormone levels in patients with carcinoid syndrome. J Clin Endocrinol Metab 1989; 68: 796
   PubMed Web of Science ®Google Scholar
• Nobin A, Axelsson S, Falck B, et al. Selective catheterization and plasma serotonin determination in patients with carcinoid tumours. World J Surg 1983; 7: 223
   PubMed Web of Science ®Google Scholar
• Åhlund L, Kindblom L G, Nilsson O, et al. Clinical and experimental studies on a midgut carcinoid tumour. J Surg Oncol 1989; 41: 86
   PubMed Web of Science ®Google Scholar
• Ahlman H, Dahlström A, Enerbäck L, et al. Two cases of gastric carcinoids: Diagnostic and therapeutic aspects. World J Surg 1988; 12: 356
   PubMed Web of Science ®Google Scholar
• Conlon J M, Deacon C F, Richter G, Stöckmann F, Creutzfeldt W C. Circulating tachykinins (substance P, neurokinin A, neuropeptide K) and the carcinoid flush. Scand J Gastroenterol 1987; 22: 97
   PubMed Web of Science ®Google Scholar
• Robertson J IS, Peart W S, Andrews T M. The mechanism of facial flush in the carcinoid syndrome. Q J Med 1962; 31: 103
   PubMedGoogle Scholar
• Oates J A, Melmon K, Sjoerdsma A, Gillespie L, Mason D T. Release of a kinin peptide in the carcinoid syndrome. Lancet 1964; 1: 514
   PubMed Web of Science ®Google Scholar
• Lucas K J, Feldman J M. Flushing in the carcinoid syndrome and plasma kallikrein. Cancer 1986; 58: 2290
   PubMed Web of Science ®Google Scholar
• Gustafsen J, Boesby S, Nielsen F, Giese J. Bradykinin in carcinoid syndrome. Gut 1987; 28: 1417
   PubMed Web of Science ®Google Scholar
• Dunér H, Pernow B. Circulatory studies on substance P in man. Acta Physiol Scand 1960; 49: 261
   PubMedGoogle Scholar
• Furchgott R F, Zawadski J V. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980; 88: 373
   Google Scholar
• Sandler M, Karim S MM, Williams E D. Prostaglandins in amine-peptide-secreting tumours. Lancet 1968; 2: 1053
   PubMed Web of Science ®Google Scholar
• Smith A G, Greaves M W. Blood prostaglandin activity associated with noradrenaline-provoked flush in the carcinoid syndrome. Br J Dermatol 1974; 90: 547
   PubMed Web of Science ®Google Scholar
• Jaffe B M, Condon S C. Prostaglandins E and F in endocrine diarrheagenic syndromes. Ann Surg 1976; 194: 516
   Google Scholar
• Roberts L J, Marney S R, Oates J A. Blockade of the flush associated with metastatic gastric carcinoid by combined H1-and H2-receptor antagonists: evidence for an important role of H2-receptors in human vasculature. N Engl J Med 1979; 300: 236
   PubMed Web of Science ®Google Scholar
• Howlett T A, Drury P L, Perry L, Doniach I, Rees L H, Besser G M. Diagnosis and management of ACTH-dependent Cushing's syndrome: comparison of features in ectopic and pituitary ACTH production. Clin Endocrinol 1986; 24: 699
   PubMed Web of Science ®Google Scholar
• Hearn P R, Reynolds C L, Johansen K, Woodhouse N JY. Lung carcinoid with Cushing's syndrome: control of serum ACTH and Cortisol levels using SMS 201–955 (Sandostatin). Clin Endocrinol 1988; 28: 181
   PubMed Web of Science ®Google Scholar
• Wilson D M, Hoffman A R. Reduction in pituitary size by the somatostatin analogue SMS 201–995 in a patient with an islet cell tumour secreting growth hormone releasing factor. Acta Endocrinol (Copenh) 1986; 113: 23
   PubMedGoogle Scholar
• von Werder K, Losa M, Stalla G K. Long-term treatment of metastasizing GRFoma with a somatostatin analogue (SMS 201–995) in a girl with gigantism. Scand J Gastroenterol 1986; 21: 238
   Web of Science ®Google Scholar
• Ch'ng J L, Christofides N D, Kraenzlin M E, et al. Growth hormone secretion dynamics in a patient with ectopic growth hormone releasing factor production. Am J Med 1985; 79: 135
   PubMed Web of Science ®Google Scholar
• McEntee G O, Naganney D M, Kvols L K, Moertel C G, Grant C S. Cytoreductive hepatic surgery for neuroendocrine tumors. Surgery 1990; 108: 1091
   PubMed Web of Science ®Google Scholar
• Aune S, Schistad G. Carcinoid liver metastases treated with hepatic dearterialization. Am J Surg 1972; 123: 715
   PubMed Web of Science ®Google Scholar
• Bengmark S, Ericsson M, Lundquist A, Mårtensson H, Nobin A, Sako M. Temporary dearterialization in patients with metastatic carcinoid disease. World J Surg 1982; 6: 46
   PubMed Web of Science ®Google Scholar
• Geterud K, Tylén U, Jansson S, Stenqvist O, Tisell L E, Ahlman H. Hepatic arterial embolisation in the treatment of the midgut carcinoid syndrome and other advanced endotrine tumours metastatic to the liver. J Intervent Radiol 1990; 5: 69
   Google Scholar